west
african
outbreak
ebola
viru
diseas
unpreced
scale
result
transmiss
outsid
endem
countri
clinician
nonendem
countri
like
face
diseas
return
travel
either
among
healthcar
worker
expatri
visit
friend
rel
clinic
suspicion
diseas
must
heighten
travel
contact
present
compat
clinic
syndrom
strict
infect
control
measur
must
promptli
implement
minim
risk
secondari
transmiss
within
healthcar
set
commun
present
concis
review
human
filovir
diseas
emphasi
issu
pertin
clinician
practic
nonendem
countri
largest
outbreak
ebola
viru
diseas
evd
histori
renew
interest
filovirus
provid
unpreced
impetu
develop
new
therapeut
vaccin
highli
lethal
infect
hemorrhag
fever
caus
ebola
marburg
virusesdalso
collect
known
filovir
hemorrhag
fever
fhf
dprevious
caus
dramat
albeit
limit
outbreak
central
africa
impact
global
health
rather
small
except
realm
biolog
warfar
research
high
mortal
rate
lack
effect
antivir
therapi
vaccin
potenti
persontoperson
transmiss
west
african
outbreak
evd
prove
filovirus
longer
consid
mere
region
problem
short
review
evd
clinic
relev
nonendem
countri
present
current
epidem
caus
ebolaviru
howev
refer
also
made
relat
marburgviru
share
mani
virolog
clinic
epidemiolog
characterist
conflict
interest
author
conflict
interest
relev
articl
order
mononegaviral
consist
envelop
nonseg
negativesens
singlestrand
rna
virus
famili
filovirida
compris
three
genera
cuevaviru
ebolaviru
marburgviru
sole
speci
cuevaviru
lloviu
cuevaviru
describ
discov
investig
massiv
dieoff
miniopteru
schreibersii
bat
franc
spain
portug
viru
detect
bat
carcass
collect
northern
spain
genu
ebolaviru
name
filoviru
describ
uniqu
morpholog
characterist
virus
virion
gener
filament
latin
filum
mean
thread
diamet
approxim
nm
highli
variabl
length
nm
may
also
appear
branch
filament
short
rod
ushap
circular
hairpinshap
genom
ebov
marv
approxim
kb
consist
seven
gene
end
nucleoprotein
np
glycoprotein
gp
rnadepend
rna
polymeras
l
ebolaviru
express
addit
protein
transcript
edit
gp
gene
addit
gp
smaller
secret
glycoprotein
sgp
produc
excret
extracellularli
c
ebov
marv
stabl
resist
desicc
probabl
explain
stabil
aerosol
droplet
howev
inactiv
heat
common
disinfect
deterg
phenol
hypochlorit
usual
heat
treatment
clinic
sampl
c
minut
may
fail
render
specimen
noninfecti
thermal
inactiv
c
minut
c
minut
necessari
gamma
irradi
readili
inactiv
filovirus
although
method
may
readili
avail
routin
clinic
laboratori
set
genet
molecular
biolog
filovir
genom
previous
review
addit
essenti
function
viral
replic
assembl
mani
viral
protein
exert
effect
host
immun
system
may
contribut
pathogenesi
infect
tabl
exampl
inhibit
normal
antivir
activ
type
interferon
multipl
step
pathway
wherea
sgp
may
contribut
immun
evas
absorb
antigp
antibodi
ie
antigen
subvers
essenti
role
mani
viral
protein
replic
assembl
viral
protein
eg
potenti
target
antivir
agent
develop
recent
year
pathogenesi
fhf
better
elucid
filovirus
pantrop
abil
infect
differ
host
cell
type
initi
cell
virus
replic
like
dendrit
cell
macrophag
monocyt
kupffer
cell
site
entri
larg
number
lectin
eg
dcsign
lsign
immunorecognit
receptor
ie
trigger
receptor
express
myeloid
cell
trem
serv
receptor
virus
initi
multipl
aforement
cell
type
virus
transport
reticuloendotheli
system
eg
lymph
node
spleen
liver
organ
infect
cell
type
occur
result
massiv
necrosi
end
organ
damag
reflect
histopatholog
human
primat
infect
model
necrosi
liver
kidney
lung
lymphoid
tissu
organ
addit
variou
mechan
contribut
develop
coagulopathi
dissemin
intravascular
coagul
hallmark
viral
hemorrhag
fever
patient
fhf
develop
signific
platelet
dysfunct
mere
account
thrombocytopenia
contribut
platelet
activ
decreas
vascular
endothelium
product
prostacyclin
anoth
import
target
pathogenesi
fhf
endothelium
human
primat
endotheli
cell
suscept
infect
ebov
although
direct
cyopath
effect
import
factor
develop
vasculopathi
coagulopathi
releas
vasoact
tabl
filoviru
gene
function
factor
eg
nitric
oxid
cytokin
chemokin
monocyt
macrophag
eg
tumor
necrosi
factoralpha
interferon
monocyt
chemoattact
could
import
genesi
vascular
damag
combin
effect
increas
secret
proinflammatori
cytokin
activ
coagul
cascad
consumpt
andor
reduc
product
protein
c
thrombocytopenia
platelet
dysfunct
hepat
damag
impair
product
coagul
factor
vascular
damag
contribut
develop
coagulopathi
fhf
protect
humor
cellular
immun
respons
demonstr
patient
surviv
antibodi
level
persist
year
addit
variou
immun
evas
mechan
allud
previous
eg
bind
antigp
antibodi
sgp
ie
immun
subvers
suppress
innat
immun
respons
inhibit
interferon
pathway
potenti
virul
pathogen
mechan
filovirus
np
protein
identifi
gener
antibodi
toward
gp
critic
protect
efficaci
vaccin
ebolaviru
marv
geograph
restrict
caus
outbreak
subsaharan
africa
howev
rebov
found
nonhuman
primat
pig
philippin
tabl
first
filoviru
discov
outbreak
marburg
hemorrhag
fever
infect
germani
infect
origin
cercopithecu
aethiop
monkey
import
uganda
first
natur
outbreak
zebov
occur
northern
call
democrat
republ
congo
sebov
discov
outbreak
nzara
sudan
bebov
caus
outbreak
uganda
follow
anoth
outbreak
democrat
republ
congo
tafv
discov
swiss
biologist
acquir
infect
republ
divoir
ie
ivori
coast
rebov
first
discov
monkey
macaca
fasciculari
export
philippin
reston
virginia
usa
infect
monkey
subsequ
export
itali
texa
cynomolgu
macaqu
philippin
natur
infect
pig
rebov
viru
appear
nonpathogen
human
human
filoviru
infect
primari
zoonot
diseas
high
propens
interperson
transmiss
primari
anim
reservoir
ebov
marv
bat
especi
fruit
bat
bat
support
longterm
viral
replic
without
develop
diseas
virolog
serolog
studi
confirm
filovir
infect
divers
bat
speci
philippin
china
bangladesh
also
evid
rebov
possibl
filovir
infect
bat
case
fhf
epidemiolog
link
contact
bat
carcass
spelunk
among
tourist
outbreak
among
gold
miner
work
cave
peak
season
bat
marv
infect
correl
incid
human
spillov
infect
primat
also
natur
infect
filovirus
although
like
infect
natur
reservoir
host
eg
bat
consid
import
reservoir
primat
nevertheless
remain
import
vector
introduct
diseas
human
rural
africa
wild
anim
mortal
sometim
preced
human
outbreak
evd
mammal
infect
evd
includ
pig
especi
rebov
zebov
dog
howev
role
caus
human
evd
outbreak
uncertain
human
infect
typic
occur
pattern
transmiss
inhabit
endem
area
especi
individu
dwell
forest
occup
exposur
wild
anim
eg
hunter
peopl
handl
bushmeat
may
develop
symptomat
subclin
infect
presum
exposur
anim
reservoir
viru
case
human
infect
histori
direct
exposur
anim
carcass
primat
bat
duiker
antelop
porcupin
indirect
exposur
bat
cave
occur
singl
multipl
introduct
human
popul
may
result
short
chain
human
transmiss
fhf
patient
admit
healthcar
facil
infect
control
measur
inadequ
larg
outbreak
may
occur
transmiss
patient
healthcar
worker
hospit
major
amplifi
dissemin
factor
mani
previou
outbreak
fhf
africa
direct
persontoperson
transmiss
ebov
marv
occur
via
blood
bodi
fluid
percutan
inocul
mucos
exposur
outbreak
sebov
viru
detect
viral
cultur
revers
transcript
polymeras
chain
reaction
rtpcr
patient
saliva
skin
swab
stool
tear
breast
milk
semen
environment
sampl
view
persist
virus
semen
breast
milk
day
day
respect
ill
onset
use
condom
withhold
breastfeed
recommend
convalesc
patient
kitwit
outbreak
democrat
republ
congo
secondari
case
household
risk
highest
peopl
direct
physic
contact
bodi
fluid
symptomat
patient
exposur
patient
late
stage
diseas
find
explain
high
viral
load
phase
diseas
reus
needl
medic
instrument
without
adequ
steril
needl
stick
injuri
lack
isol
facil
inadequ
inappropri
use
person
protect
equip
contribut
explos
hospit
outbreak
african
burial
custom
wash
dead
bodi
transport
bodi
without
barrier
precaut
transmit
diseas
commun
infect
pig
transmit
rebov
nonhuman
primat
via
airborn
rout
nonhuman
primat
infect
experiment
inhal
droplet
droplet
size
mm
although
parenter
infect
primat
transmit
infect
via
airborn
rout
true
airborn
transmiss
ebov
human
likewis
document
patient
ebov
outbreak
may
known
contact
exposur
histori
although
remain
unclear
whether
fomit
true
airborn
transmiss
inadequ
investig
tabl
outbreak
human
filoviru
infect
viru
ongo
evd
outbreak
time
write
uniqu
two
aspect
unpreced
scale
origin
west
africa
guinea
rather
central
africa
first
case
occur
guinea
februari
subsequ
spread
african
countri
liberia
sierra
leon
nigeria
seneg
mali
octob
world
health
organ
declar
epidem
seneg
nigeria
epidemiolog
investig
suggest
index
case
probabl
child
die
decemb
southern
guinea
infect
subsequ
transmit
child
famili
member
villag
midwif
healthcar
worker
patient
later
caus
outbreak
differ
area
guinea
ebola
viru
diseas
caus
infect
local
healthcar
worker
worker
die
januari
four
infect
healthcar
worker
citizen
unit
state
america
spain
unit
kingdom
return
respect
countri
manag
hand
asymptomat
infect
describ
evidenc
seroconvers
close
contact
patient
two
zebov
outbreak
gabon
seroconvert
asymptomat
contact
rtpcr
peripher
blood
mononuclear
cell
posit
viru
viremia
persist
week
contact
anoth
line
evid
asymptomat
infect
come
seropreval
studi
africa
survey
popul
central
africa
seroposit
ebov
seropreval
consist
higher
among
forestdwel
popul
hunter
incub
period
evd
vari
day
day
commonli
day
recent
analysi
case
zebov
outbreak
kitwit
suggest
mean
incub
period
day
maximum
incub
period
day
biphas
ill
describ
appar
remiss
day
diseas
usual
begin
abruptli
nonspecif
symptom
fever
patient
ut
infra
malais
headach
sore
throat
odynophagia
dysphagia
hiccough
nonproduct
cough
abdomin
pain
nausea
vomit
often
preced
onset
diarrhea
usual
day
onset
ill
abdomen
tender
palpat
absenc
support
therapi
diarrhea
vomit
may
lead
fluid
deplet
electrolyt
disturb
hypokalemia
symptom
includ
arthralgia
myalgia
chest
pain
conjunctiv
inject
diffus
erythemat
rash
appear
toward
end
st
week
later
desquam
nonprurit
rash
appear
first
trunk
spread
entir
bodi
spare
face
three
earli
symptom
bilater
conjunctiv
inject
rash
sore
throat
suggest
evd
differenti
diagnosi
appear
rash
patient
may
either
gradual
recov
sever
case
progress
day
fullblown
hemorrhag
fever
syndrom
petechia
gum
bleed
melaena
hemoptysi
hematemesi
epistaxi
hematuria
menorrhagia
bleed
venipunctur
site
show
featur
dissemin
intravascular
coagul
typic
hemorrhag
fever
pictur
howev
occur
approxim
patient
rang
manifest
late
stage
includ
evid
multiorgan
failur
circulatori
shock
obtund
tachypnea
renal
shutdown
convuls
delirium
coma
fever
often
absent
stage
death
often
occur
day
wherea
patient
surviv
show
improv
around
day
intrauterin
death
common
pregnant
patient
mortal
among
pregnant
women
substanti
may
significantli
higher
nonpregn
patient
pregnant
women
increas
suscept
infect
survivor
tend
improv
nd
week
ill
make
slow
recoveri
arthralgia
could
asymmetr
migratori
often
involv
larg
joint
uveiti
conjunct
orchiti
parot
hear
loss
tinnitu
may
occur
chronic
infect
filovirus
document
male
patient
may
shed
viru
semen
day
onset
ill
transmiss
marv
occur
via
sexual
intercours
common
laboratori
find
includ
lymphopenia
thrombocytopenia
elev
aminotransferas
hyperproteinemia
proteinuria
prolong
prothrombin
activ
partial
thromboplastin
time
progress
diseas
evid
dissemin
intravascular
coagul
renal
failur
appear
diseas
progress
also
associ
worsen
lymphopenia
rise
antigenemia
compar
survivor
patient
fatal
evd
like
tachypnea
patient
diseas
also
significantli
higher
level
viremia
much
weaker
humor
immun
respons
infect
signific
differ
number
cytokin
chemokin
level
also
detect
patient
nonfat
fatal
evd
particular
level
mani
proinflammatori
cytokin
nitric
oxid
higher
nonsurvivor
possibl
except
bebov
wherea
level
cell
cell
lower
high
viral
load
prognost
signific
sebov
fhf
patient
fatal
case
averag
copi
rnaml
serum
compar
approxim
copi
rnamll
serum
survivor
patient
marv
fhf
likewis
high
level
viremia
blood
median
level
rang
ml
serum
serum
pathognomon
sign
symptom
earli
stage
evd
use
histori
epidemiolog
linkag
possibl
case
travel
histori
contact
known
suspect
case
laboratori
investig
necessari
confirm
diagnosi
differenti
diagnos
vide
infra
exclud
appropri
clinic
specimen
must
handl
great
care
collect
transport
test
laboratori
laboratoryacquir
infect
ebov
occur
via
percutan
exposur
marburgviru
retain
infect
dri
blood
least
day
filovirus
inactiv
heat
c
minut
c
minut
c
minut
presenc
final
concentr
sodium
dodecyl
sulfat
final
concentr
tween
inactiv
sodium
deoxychol
solut
aceton
diethyl
ether
formalin
methanol
sodium
hypochlorit
glutaraldehyd
peracet
acid
phenol
disinfect
osmium
tetroxid
use
fixat
electron
microscopi
ultraviolet
light
effect
mean
surfac
disinfect
depend
type
specimen
test
methodolog
treatment
sampl
either
triton
tween
sodium
dodecyl
sulfat
betapropiolacton
chloramin
b
acet
acid
ph
done
routin
hematolog
biochem
serolog
test
heat
inactiv
recommend
blood
sodium
potassium
magnesium
urat
urea
creatinin
bilirubin
glucos
creactiv
protein
howev
method
inactiv
would
necessari
calcium
phosphat
albumin
transaminas
gammaglutamyltransferas
creatin
kinas
determin
standard
virolog
techniqu
also
appli
diagnosi
fhf
includ
viral
cultur
electron
microscopi
serolog
test
use
antigen
antibodi
detect
nucleic
acid
amplif
filovirus
cultiv
clinic
specimen
especi
blood
liver
sampl
howev
associ
biohazard
viral
cultur
notdand
bedroutin
perform
except
facil
handl
biosafeti
level
agent
electron
microscopi
excel
specif
uniqu
morpholog
filovirus
also
routin
perform
biosafeti
consider
limit
avail
electron
microscop
facil
routin
diagnost
set
rel
high
viral
load
necessari
visual
detect
antibodi
eg
immunoglobulin
igm
immunoglobulin
g
igg
commonli
achiev
use
immunofluoresc
assay
enzymelink
immunoassay
elisa
recombin
np
gp
antigen
appear
igm
igg
antibodi
occur
approxim
day
day
respect
onset
ill
variou
antigen
detect
assay
develop
diagnosi
fhf
use
field
situat
techniqu
includ
antigencaptur
elisa
immunofluoresc
assay
dotimmunobind
assay
immunofiltr
assay
differ
genusspecif
speciesspecif
reactiv
toward
common
target
np
gp
protein
practic
limit
serolog
assay
limit
avail
test
laboratori
nonendem
countri
nucleic
acid
amplif
diagnost
test
choic
high
sensit
especi
earli
phase
ill
abil
differenti
differ
agent
viral
hemorrhag
fever
rel
lower
biohazard
virus
appropri
inactiv
antigen
antibodi
assay
often
unavail
laboratori
nonendem
countri
viral
load
determin
quantit
assay
prognost
inform
also
obtain
commonli
use
test
rtpcr
revers
transcriptioneloopmedi
isotherm
amplif
assay
also
develop
ebov
marv
diagnost
nucleic
acid
amplif
test
must
adequ
valid
use
clinic
appropri
valid
use
multiplex
pcrrtpcr
allow
simultan
detect
multipl
pathogen
caus
hemorrhag
fever
provis
nucleic
acid
amplif
test
prefer
central
nation
region
refer
laboratori
ensur
adequ
biosafeti
contain
qualiti
result
rna
ebov
detect
sera
rtpcr
hour
earlier
antigen
captur
studi
detect
day
ill
howev
viral
load
gradual
reach
peak
approxim
day
onset
diseas
retest
therefor
necessari
rtpcr
initi
neg
clinic
suspicion
high
especi
first
sampl
obtain
within
day
onset
diseas
blood
commonli
use
sampl
rtpcr
oral
fluid
specimen
viabl
altern
blood
sampl
rtpcr
situat
blood
take
may
difficult
infeas
common
target
nucleic
acid
amplif
includ
l
gp
np
gene
clinic
manag
vaccin
develop
treatment
fhf
primarili
support
owe
unavail
approv
specif
antivir
agent
concurr
infect
malaria
bacteri
sepsi
treat
appropri
fluid
electrolyt
replac
blood
product
transfus
renal
replac
therapi
ventilatori
support
extracorpor
membran
oxygen
administ
necessari
variou
experiment
therapeut
approach
attempt
experiment
anim
clinic
howev
random
control
trial
prove
efficaci
exampl
includ
recombin
inhibitor
factor
vii
recombin
human
activ
protein
c
interferonbeta
case
sever
viral
infect
convalesc
plasma
recov
patient
use
treat
fhf
deploy
appar
benefit
evd
outbreak
kitwit
world
health
organ
publish
guidelin
collect
prepar
convalesc
plasma
use
outbreak
situat
howev
recogn
uncertainti
efficaci
treatment
cocktail
monoclon
antibodi
similarli
use
recent
success
reduc
mortal
ebov
infect
nonhuman
primat
antibodi
produc
plant
mice
base
studi
optim
cocktail
plantderiv
monoclon
antibodi
call
zmapp
produc
protect
rhesu
macaqu
infect
day
ebov
antibodi
use
experiment
treat
human
ebov
patient
west
african
outbreak
although
actual
benefit
human
evd
remain
confirm
second
approach
treatment
fhf
lie
develop
specif
antivir
agent
current
nucleotid
analogu
favipiravir
develop
approv
japan
treatment
influenza
favipiravir
inhibit
viral
rnadepend
rna
polymeras
influenza
viru
subsequ
found
exhibit
vitro
antivir
activ
certain
rna
virus
bunyavirus
arenavirus
flavivirus
alphavirus
noroviru
ebov
anim
studi
also
demonstr
efficaci
favipiravir
treatment
viru
arenaviru
ebov
hemorrhag
fever
drug
use
treat
human
evd
west
african
epidem
dose
regimen
favipiravir
use
clinic
trial
treatment
evd
publish
anoth
nucleotid
analogu
brincidofovir
lipid
conjug
cidofovir
previous
develop
treat
infect
due
dna
virus
adenovirus
herpesvirus
orthopoxvirus
drug
grant
emerg
investig
new
drug
applic
octob
unit
state
us
food
drug
administr
evalu
evd
treatment
clinic
trial
start
januari
monrovia
liberia
nucleosid
analogu
recent
shown
inhibit
rna
polymeras
negativeand
positivesens
rna
virus
via
chain
termin
effect
vivo
activ
marv
demonstr
guinea
pig
cynomolgu
macaqu
develop
human
clinic
trial
requir
long
time
anoth
approach
involv
screen
current
avail
nonantimicrobi
activ
filovirus
compound
select
estrogen
receptor
modul
eg
clomiphen
toremifen
amiodaron
dronedaron
verapamil
antifiloviru
activ
cell
cultur
andor
murin
model
addit
rna
interfer
use
small
interf
rna
provid
postexposur
protect
anim
infect
ebov
marv
third
approach
specif
manag
filovir
infect
explor
potenti
postexposur
prophylaxi
regimen
would
benefit
expos
healthcar
worker
social
contact
laboratori
staff
experienc
accident
exposur
protect
immun
toward
filovirus
exist
demonstr
possibl
benefit
convalesc
plasma
anim
studi
humor
immun
ie
igg
protect
ebov
infect
anim
studi
also
confirm
passiv
immun
neutral
monoclon
antibodi
protect
primat
previous
examin
filoviru
vaccin
candid
elicit
protect
humor
immun
experiment
includ
ebovlik
particl
contain
gp
np
replicationdefici
ebov
mutant
lack
gene
ebov
gpcontain
fragment
fusion
protein
phase
clinic
trial
test
dna
vaccin
encod
glycoprotein
ebov
marv
one
promis
vaccin
candid
filovirus
recombin
vesicular
stomat
virusbas
vaccin
system
express
filovir
gp
system
elicit
protect
immun
zebov
sebov
bebov
marv
also
offer
substanti
postexposur
prophylaxi
primat
murin
model
vaccin
use
postexposur
prophylaxi
laboratori
staff
person
sustain
needl
stick
injuri
zebov
similar
vaccin
system
use
replicationdefect
recombin
adenoviru
express
ebov
gp
protect
anim
model
phase
clinic
trial
vesicular
stomat
virusbas
adenovirusbas
vaccin
began
late
ebola
viru
diseas
problem
nonendem
countri
issu
prevent
control
contain
fhf
outbreak
endem
countri
requir
substanti
resourc
coordin
public
health
system
author
countri
surveil
diseas
educ
engag
local
citizen
isol
treatment
facil
laboratori
support
requir
often
beyond
capabl
endem
countri
signific
intern
assist
usual
need
contain
major
outbreak
discuss
public
health
issu
beyond
scope
articl
health
author
nonendem
countri
prepared
plan
emerg
infect
indispens
compon
public
health
system
develop
adopt
prepared
respons
plan
emerg
infecti
diseas
first
foster
anticip
pandem
influenza
outbreak
sever
acut
respiratori
syndrom
sar
pandem
influenza
ie
middl
east
respiratori
syndrom
coronaviru
merscov
recent
avian
influenza
ie
evd
underscor
import
preemptiv
plan
prevent
mitig
effect
diseas
transmiss
detail
may
vari
depend
natur
pathogen
howev
key
compon
public
health
respons
includ
risk
assess
commun
educ
establish
rapid
respons
team
manag
team
coordin
respons
differ
govern
ministri
monitor
surveil
provid
adequ
facil
suppli
quarantin
infect
control
develop
laboratori
diagnost
appropri
antimicrobi
vaccin
polici
andor
stockpil
clinician
nonendem
countri
fhf
mostli
encount
travel
return
endem
area
sar
epidem
influenza
pandem
demonstr
effici
intern
traveldespeci
air
traveldin
global
spread
infecti
diseas
contin
africa
rel
small
number
intern
travel
oceania
smaller
number
intern
tourist
arriv
although
export
fhf
nonendem
countri
well
document
present
epidem
tempt
consid
establish
travel
restrict
limit
spread
evd
outsid
africa
howev
actual
benefit
polici
limit
time
write
issu
travel
restrict
affect
countri
howev
prudent
issu
health
warn
potenti
visitor
affect
countri
pretravel
educ
transmiss
rout
precautionari
measur
selfmonitor
sign
symptom
avail
medic
care
destin
countri
provid
subspecialti
travel
medicin
visit
friend
rel
vfr
particularli
high
risk
contract
travelrel
infect
despit
fact
public
health
alert
often
announc
gener
public
vfr
alway
receiv
necessari
inform
risk
cultur
differ
languag
barrier
differ
percept
henc
effort
must
target
vfr
especi
african
commun
context
reduc
risk
diseas
import
remot
infrar
thermal
scanner
use
mean
fever
screen
airport
countri
practic
first
gain
popular
sar
epidem
subsequ
evalu
influenza
pandem
lesser
extent
method
also
use
screen
febril
ill
dengu
fever
infrar
thermal
scan
rel
popular
asian
countri
taiwan
japan
korea
hong
kong
usual
use
conjunct
health
questionnair
selfreport
symptom
fever
travel
histori
tympan
temperatur
would
measur
suspect
case
sensit
specif
posit
predict
valu
thermal
scan
affect
varieti
factor
instrument
use
threshold
temperatur
part
bodi
measur
distanc
instrument
individu
previou
use
antipyret
agent
patient
incub
period
infect
obvious
detect
screen
method
despit
rel
low
sensit
specif
posit
predict
valu
infrar
thermal
scan
investig
consid
use
adjunct
measur
border
screen
although
reli
sole
method
screen
contact
trace
must
promptli
initi
potenti
contact
return
travel
diagnos
communic
infecti
diseas
evd
detail
guidanc
contact
trace
patient
evd
form
viral
hemorrhag
fever
publish
suspect
contact
must
undergo
individu
risk
assess
base
travel
histori
epidem
situat
affect
countri
natur
potenti
exposur
travel
detail
instruct
inform
must
provid
contact
monitor
fever
develop
symptom
monitor
may
perform
commun
within
healthcar
facil
limit
indor
least
advic
againstdth
freedom
travel
within
commun
countri
may
necessari
interfer
daili
activ
may
inevit
close
empathet
liaison
contact
health
depart
essenti
ensur
complianc
monitor
minim
psycholog
impact
prepared
plan
contact
trace
diseas
surveil
clinic
manag
isol
precaut
outbreak
manag
must
place
manag
incid
nonendem
countri
hemorrhag
fever
remain
uncommon
caus
fever
return
travel
although
sever
clinic
substanti
public
health
implic
risk
fhf
return
travel
low
ten
case
marburg
hemorrhag
fever
report
patient
travel
histori
africa
case
import
evd
exclud
nonpathogen
rebov
describ
south
africa
zebov
switzerland
tafv
caus
fever
set
must
exclud
appropri
laboratori
investig
includ
depend
itinerari
exposur
histori
caus
fever
without
hemorrhag
present
meningococc
infect
sever
sepsi
due
bacteri
infect
includ
rare
infect
anthrax
plagu
guid
clinic
pictur
exposur
histori
leptospirosi
typhoid
caus
enter
fever
rickettsios
malaria
trypanosomiasi
viscer
leishmaniasi
dengu
fever
yellow
fever
particular
malaria
common
treatabl
caus
fever
return
travel
endem
subsaharan
africa
must
exclud
appropri
test
depend
travel
destin
caus
viral
hemorrhag
fever
consid
lassa
fever
hantaviru
infect
crimeancongo
hemorrhag
fever
rift
valley
fever
travel
histori
also
includ
human
contact
sick
individu
commun
eg
attend
local
funer
healthcar
facil
case
volunt
worker
anoth
import
exposur
histori
interact
bat
wild
anim
especi
primat
exampl
histori
spelunk
result
fhf
among
local
citizen
foreign
visitor
case
marburg
hemorrhag
fever
occur
exposur
visitor
bat
cave
kenya
uganda
fhf
suspect
base
travel
andor
exposur
histori
preemptiv
isol
essenti
minim
risk
subsequ
interperson
spread
diagnosi
exclud
rout
transmiss
filovirus
well
document
transmiss
interrupt
provid
proper
infect
control
public
health
measur
implement
detail
infect
control
guidelin
care
patient
fhf
publish
essenc
principl
isol
use
person
protect
equip
significantli
differ
standard
precaut
transmissionbas
precaut
ie
contact
droplet
airborn
univers
practic
healthcar
facil
howev
numer
studi
review
confirm
complianc
choic
use
person
protect
equip
among
healthcar
worker
almost
alway
suboptim
essenti
factor
ensur
optim
implement
infect
control
protocol
adequ
train
healthcar
worker
isol
procedur
appropri
use
person
protect
equip
prefer
interact
train
clear
instruct
adequ
manpow
organiz
support
avail
time
adequ
guidanc
support
train
limit
staff
work
clinic
area
must
also
includ
healthcar
worker
laboratori
worker
paramed
personnel
key
element
infect
control
consist
patient
placement
eg
isol
facil
strict
adher
hand
hygien
eg
five
moment
hand
hygien
proper
use
person
protect
equip
glove
eg
doubl
glove
special
circumst
waterproof
gown
respiratori
protect
eg
surgic
mask
respir
aerosolgener
procedur
eye
protect
rubber
boot
safe
handl
sharp
object
support
staff
engag
environment
disinfect
funer
burial
servic
must
also
adequ
train
proper
use
person
protect
equip
chemic
disinfect
handl
human
remain
ensur
adequ
disinfect
minim
risk
accident
exposur
viru
conclus
filovir
hemorrhag
fever
uncommon
pose
real
clinic
public
health
threat
countri
outsid
endem
area
rout
transmiss
clinic
manifest
infect
control
measur
well
document
prevent
secondari
transmiss
possibl
provid
case
promptli
identifi
standard
isol
precautionari
measur
strictli
follow
case
pandem
influenza
epidemicpron
infect
prepared
plan
essenti
cope
import
diseas
limit
subsequ
spread
minim
risk
diseas
import
essenti
concert
program
engag
vfr
atrisk
travel
commun
health
educ
advisori
current
evd
outbreak
provid
opportun
evalu
new
therapeut
prophylact
strategi
wherea
actual
valu
strategi
control
current
futur
epidem
requir
detail
clinic
evalu
